Skip to main content
Premium Trial:

Request an Annual Quote

3rd Mill Draws on Klemm s Incyte into Informatics

Premium

Juli Klemm, who joined 3rd Millennium as senior project scientist, says custom-made is the way to go for informatics companies. “These companies have very specific needs. Off-the-shelf solutions aren’t cutting it,” says Klemm, who spent four years at Incyte Genomics, where she worked her way up to director of scientific project management.

Her position requires her to be a “jack of all trades,” Klemm, 34, says. She’s responsible for meeting with clients and determining what answers the company can provide to solve problems with life sciences software. “[We] can come in and bring experience to these things [and] design something that’s custom for these people,” she says.

Klemm, who headed to Incyte after a postdoc at Stanford, hopes her experience with a larger company will help the smaller, Boston-based firm, where she landed after her husband took a faculty position in Worcester, Mass. Hunting for a job turned out to be a good thing, she says. “In a funny way it was educational to be able to step back and do this sort of survey, having an opportunity to talk to a lot of companies.” In the end, she was lured to the consulting firm. “In this economy, I was really struck by how well this small company had done.”

So far, 3rd Millennium is certainly taking advantage of her project-management skills: she’s already working on a LIMS system for a major research institute, a knowledge management project for another client, and an internal project to build a pathways system.

Klemm cringes when asked where she’s originally from. “My dad was in the Army.” So she’s heard her share of Army brat jokes: “I should have a compendium of them,” she laughs.

— Meredith Salisbury

 

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.